Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BCT.TOthis companyBriaCell Therapeutics Corp.	CA$5.57	-0.68×	1.47×	0×	-0.39×	-83.3%	0.0%	0.0%	0.0%	-216.0%	-234.6%	-120.9%	0×	0.27×	0×	2.76×	0.0%	1	-10.15	2	C
DOSE.CNRapid Dose Therapeutics Corp.	CA$0.11	-5.88×	-2.78×	7.19×	-15.23×	-398.4%	-34.5%	-78.3%	-122.2%	47.2%	117.1%	-1.4%	-0.74×	-3.2×	-1.78×	0.04×	0.0%	3	-27.84	2	C
GWAY.CNGreenway Greenhouse Cannabis Corporation	CA$0.08	-8.81×	2.91×	3.02×	82.82×	-4824.0%	2.5%	-19.3%	-34.4%	-33.1%	-6.2%	-8.9%	2.01×	32.35×	-1.17×	0.48×	0.0%	1	-0.99	—	—
HEM.VHemostemix Inc.	CA$0.05	-3.13×	-2.96×	0×	-4.14×	-154.2%	0.0%	0.0%	0.0%	94.8%	637.9%	-30.8%	-0.72×	-0.69×	-10.05×	0.49×	0.0%	1	-454.38	2	C
IZO.CNIzotropic Corporation	CA$0.13	-9.6×	-3.74×	0×	-16.94×	-159.6%	0.0%	0.0%	0.0%	38.8%	57.4%	-4.1%	-0.55×	-2.05×	-3×	0.06×	0.0%	1	-176.57	2	C
MBX.TOMicrobix Biosystems Inc.	CA$0.29	-16.46×	1.33×	1.98×	73.63×	-10.7%	53.0%	-8.5%	-12.1%	-8.1%	-4.4%	-2.4%	0.24×	-12.48×	-1.66×	8.48×	0.0%	3	1.64	2	C
Peer median	—	-8.81×	-2.78×	1.98×	-4.14×	-159.6%	0.0%	-8.5%	-12.1%	38.8%	57.4%	-4.1%	-0.55×	-2.05×	-1.78×	0.48×	0.0%	1	-27.84	2	—